Patel S, Yang E, Milne T J, Hussaini H, Cooper P R, Friedlander L T
Sir John Walsh Research Institute, Faculty of Dentistry, University of Otago, Dunedin, New Zealand.
Int Endod J. 2025 Mar;58(3):434-448. doi: 10.1111/iej.14181. Epub 2024 Dec 9.
To investigate the influence of type 2 diabetes (T2D) and hyperglycaemia on blood vessels and angiogenic markers in the dental pulp.
Extracted non-carious permanent molar teeth were collected from patients with well-controlled T2D (n = 10) and non-T2D (controls) (n = 10). The pulp was examined qualitatively using haematoxylin and eosin and Van Gieson stains. Immunohistochemistry (IHC) identified the primary receptor for VEGF, VEGFR2, and the endothelial cell marker CD34. Primary human dental pulp cell (hDPC) lines (n = 3) were established from tissue explants and cells were grown in media containing 5.5 mM D-glucose (control), 12.5 mM (prediabetes) and 25 mM (T2D) D-glucose under normoxic conditions for 24, 48 and 72 h. Assays for metabolic activity (PrestoBlue) and cell viability (Crystal Violet staining) assessed the hDPC response to hyperglycaemia. The expression of angiogenic genes VEGFA, KDR, FLT-1, ANGPT1, ANGPT2, TIE1 and TEK were analysed using quantitative real-time polymerase chain reaction. ELISAs were used to quantify the level of expressed protein for VEGFA, ANG1, ANG2, TIE1, and TIE2 in the media. Data analyses were performed using GraphPad Prism and anova tests at p < .05.
Blood vessels in T2D samples had thicker walls and stained strongly for elastin and collagen compared with non-T2D samples. VEGFR2 protein was not seen in any T2D samples but consistently detected in healthy specimens. Culturing healthy cells in high glucose (25 mM) significantly reduced cell viability at 24 h compared to the control (p = .005) and 12.5 mM glucose (p = .001) but the metabolic activity was not greatly affected by glucose and time. VEGFA mRNA and VEGFA protein expression were detected in the hDPCs in the presence of hyperglycaemia over time; however, the primary receptor, VEGFR2/KDR, was not detected. Genes for the ANG1 and ANG2 and their receptors were expressed at all glucose concentrations but hyperglycaemia upregulated ANG2 mRNA. Proteins for all growth factors were detected in the media however proteins for TIE1 and TIE2 receptors were not.
T2D and hyperglycaemia may impair the angiogenic response in the pulp similar to other body site. The scarcity of VEGFR2 and increased expression of ANG2 in response to hyperglycaemia suggests that VEGF and ANG-Tie1/Tie2 signalling may be compromised.
研究2型糖尿病(T2D)和高血糖对牙髓血管及血管生成标志物的影响。
从T2D控制良好的患者(n = 10)和非T2D患者(对照组,n = 10)中收集拔除的非龋恒磨牙。采用苏木精-伊红染色和范吉森染色对牙髓进行定性检查。免疫组织化学(IHC)鉴定血管内皮生长因子(VEGF)的主要受体VEGFR2和内皮细胞标志物CD34。从组织外植体建立原代人牙髓细胞(hDPC)系(n = 3),并在常氧条件下,将细胞培养于含5.5 mM D-葡萄糖(对照)、12.5 mM(糖尿病前期)和25 mM(T2D)D-葡萄糖的培养基中24、48和72小时。通过代谢活性检测(PrestoBlue)和细胞活力检测(结晶紫染色)评估hDPC对高血糖的反应。采用定量实时聚合酶链反应分析血管生成基因VEGFA、KDR、FLT-1、ANGPT1、ANGPT2、TIE1和TEK的表达。采用酶联免疫吸附测定法(ELISA)定量培养基中VEGFA、ANG1、ANG2、TIE1和TIE2表达蛋白的水平。使用GraphPad Prism软件和方差分析进行数据分析,p < 0.05。
与非T2D样本相比,T2D样本中的血管壁更厚,弹性蛋白和胶原蛋白染色更强。在任何T2D样本中均未见到VEGFR2蛋白,但在健康样本中始终能检测到。与对照(p = 0.005)和12.5 mM葡萄糖(p = 0.001)相比,在高糖(25 mM)条件下培养健康细胞24小时可显著降低细胞活力,但代谢活性未受葡萄糖和时间的太大影响。随着时间推移,在高血糖情况下hDPC中可检测到VEGFA mRNA和VEGFA蛋白表达;然而,未检测到主要受体VEGFR2/KDR。ANG1和ANG2及其受体的基因在所有葡萄糖浓度下均有表达,但高血糖会上调ANG2 mRNA。在培养基中检测到所有生长因子的蛋白,但未检测到TIE1和TIE2受体的蛋白。
T2D和高血糖可能与其他身体部位一样损害牙髓中的血管生成反应。VEGFR2的缺乏以及高血糖时ANG2表达增加表明VEGF和ANG-Tie1/Tie2信号可能受损。